CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF)
CUSIP: G1933S101
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Ordinary Shares
- Shares outstanding
- 35,821,764
- Total 13F shares
- 352,170
- Share change
- +100,168
- Total reported value
- $1,936,256
- Price per share
- $5.50
- Number of holders
- 23
- Value change
- +$552,357
- Number of buys
- 10
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP G1933S101?
CUSIP G1933S101 identifies CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G1933S101:
Top shareholders of CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Wellington Shields Capital Management, LLC |
13F
|
Company |
0.26%
|
92,217
|
$332,903 | — | 31 Mar 2024 | |
| Wellington Shields & Co., LLC |
13F
|
Company |
0.12%
|
43,091
|
$155,559 | — | 31 Mar 2024 | |
| HOWLAND CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.11%
|
40,429
|
$145,949 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
36,800
|
$133,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
22,221
|
$80,217 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
12,006
|
$43,342 | — | 31 Mar 2024 | |
| Catalyst Funds Management Pty Ltd |
13F
|
Company |
0.01%
|
1,810
|
$6,534 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,437
|
$5,188 | — | 31 Mar 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
623
|
$2,000 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
500
|
$1,805 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
296
|
$1,069 | — | 31 Mar 2024 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0%
|
300
|
$1,032 | — | 31 Mar 2024 | |
| WEST PACES ADVISORS INC. |
13F
|
Company |
0%
|
100
|
$361 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
53
|
$191 | — | 31 Mar 2024 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
40
|
$144 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
25
|
$90 | — | 31 Mar 2024 | |
| Mendota Financial Group, LLC |
13F
|
Company |
0%
|
20
|
$73 | — | 31 Mar 2024 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
13
|
$47 | — | 31 Mar 2024 | |
| Colonial Trust Co / SC |
13F
|
Company |
0%
|
11
|
$40 | — | 31 Mar 2024 | |
| Kozak & Associates, Inc. |
13F
|
Company |
0%
|
10
|
$32 | — | 31 Mar 2024 |
Institutional Holders of CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) as of Q2 2024
As of 30 Jun 2024,
CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
352,170 shares.
The largest 10 holders included
VR Adviser, LLC, Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, HOWLAND CAPITAL MANAGEMENT LLC, UBS Group AG, ADAR1 Capital Management, LLC, Royal Bank of Canada, and MORGAN STANLEY.
This page lists
23
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
20
Q2 2024 holders
23
Holder diff
3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.